Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
33.78
+1.12 (3.43%)
At close: Sep 26, 2025, 4:00 PM EDT
33.09
-0.69 (-2.04%)
After-hours: Sep 26, 2025, 7:04 PM EDT
Galapagos NV Market Cap
Galapagos NV has a market cap or net worth of $2.18 billion as of September 26, 2025. Its market cap has increased by 13.33% in one year.
Market Cap
2.18B
Enterprise Value
-1.42B
1-Year Change
13.33%
Ranking
Category
Stock Price
$33.78
Market Cap Chart
Since May 14, 2015, Galapagos NV's market cap has increased from $1.86B to $2.18B, an increase of 17.12%. That is a compound annual growth rate of 1.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 2.23B | 22.83% |
| Dec 31, 2024 | 1.81B | -32.28% |
| Dec 29, 2023 | 2.68B | -8.14% |
| Dec 30, 2022 | 2.91B | -19.35% |
| Dec 31, 2021 | 3.61B | -43.56% |
| Dec 31, 2020 | 6.40B | -43.18% |
| Dec 31, 2019 | 11.27B | 141.07% |
| Dec 31, 2018 | 4.67B | 7.74% |
| Dec 29, 2017 | 4.34B | 72.91% |
| Dec 30, 2016 | 2.51B | 8.12% |
| Dec 31, 2015 | 2.32B | 24.52% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 641.51B |
| Johnson & Johnson | 428.03B |
| AbbVie | 386.06B |
| UnitedHealth Group | 312.96B |
| Novo Nordisk | 251.02B |
| Novartis AG | 237.03B |
| Abbott Laboratories | 232.02B |
| AstraZeneca | 226.78B |